Recombinant CD52 (Gatralimab Biosimilar) antibody

Catalog No. ABIN7675938

The Human Monoclonal anti-CD52 (Gatralimab Biosimilar) antibody is suitable to detect CD52 (Gatralimab Biosimilar) in samples from Human. It has been validated for ELISA, BLI, FACS, Func and SPR.

Quick Overview for Recombinant CD52 (Gatralimab Biosimilar) antibody (ABIN7675938)

Target: CD52 (Gatralimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD52 (Gatralimab Biosimilar) antibody is un-conjugated

Application: ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD52 (Gatralimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD52 Reference Antibody (gatralimab)

Characteristics: Anti-CD52 Reference Antibody (gatralimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD52 (Gatralimab Biosimilar)

Target: CD52 (Gatralimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P31358